JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2016, Vol. 54 ›› Issue (1): 94-96.doi: 10.6040/j.issn.1671-7554.0.2015.693

Previous Articles    

  

  • Received:2015-07-22 Online:2016-01-11 Published:2016-01-11

CLC Number: 

  • R737
[1] Koyama T, Mikami Y, Saga T, et al. Secondary ovarian tumors: spectrum of CT and MR features with pathologic correlation[J]. Abdom Imaging, 2007, 32(6):784-795.
[2] Chen S, Paruligiani G. Meta—analysis of BRCAl and BRCA2 penetrance[J]. J Clin Oneol, 2007, 25(11):1329-1333.
[3] Vollebergh MA, Lips EH, Nederlof PM, et al. Genomic patterns resembling BRCAl-and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy[J]. Breast Cancer Res, 2014, 16(3):R47.
[4] Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCAl or BRCA2 mutations detected in case series unselected for family history: a combined analysis of22 studies[J]. Am J Hum Genet, 2003, 72(5):1117- 1130.
[5] 李向东.C-erbB-2、ER和PR在乳腺癌中的表达与预后意义[J].现代肿瘤医学,2006,14(3):289. LI Xiangdong. Expression and prognostic significance of C-erbB-2, ER and PR in breast cancer[J]. Modern Oncology Medicine, 2006, 14(3):289.
[6] Verma S, Joy AA, Rayson D, et al. HER story: the next chapter in HER-2-directed therapy for advanced breast cancer[J]. Oncologist, 2013, 18(11):1153-1166.
[7] Giordano SH, Temin S, Kirshner JJ, et al. Systemic therapy for patients with advanced human epidermal growth factor receptor2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline[J]. J Clin Oncol, 2014, 32(19):2078-2099.
[8] Verri E, Guglielmini P, Puntoni M, et al. NER2/neu oncoprotein overexpression in epitheliaI ovarian cancer: evaluation of its prevalence and prognosticsignificance[J]. Oncology, 2005, 68:154-161.
[9] 何以丰,徐丛剑,冯令达.HER2与上皮性卵巢癌术后生存率相关性的Meta分析[J].中国循证医学杂志,2007,7(6):420. HE Yifeng, XU Congjian, FENG Lingda. Meta analysis of the correlation between HER2 and the survival rate of epithelial ovarian cancer[J]. Chinese Journal of Evidence-based Medicine, 2007, 7(6):420.
[10] Camilleri-Broet S, Hardy-Bessard AC, Le Tourneau A, et al. HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group[J]. Ann Oncol, 2004, 15(1):104.
[11] Riener EK, Arnold N, Kommoss F, et al. The prognostic and predictive valw of immunohistochemically detected,Her-2 overexpression in 361 patients with ovarian cancer;a multicenter study[J]. Gynecol Oncol, 2004, 95(1):89.
[12] Wolff EF, Martel M, Gwin K, et al. Synchronous primary breast and ovarian cancer with ovarian cancer metastases to a breast sentinel lymph node[J]. Breast J, 2009, 15(2):203-205.
[13] Sandor V, Reed E, Sarosy G, et al. Synchronous inflammatory breast cancer and advanced ovarian carcinoma: a case with prolonged disease—free survival[J]. Ann Oncol, 1999, 10(5): 585-588.
[14] Lesnock JL, Darcy KM, Tian C, et al. BRCAl expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a gynecologic oncology group study[J]. Br J Cancer, 2013, 108(6):1231-1237.
[1] LI Yinglin, SONG Daoqing, XU Zhonghua. Identification of FKBP11 expression in clear cell renal cell carcinoma using bioinformatics analysis [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 45-51.
[2] GAO Pei, MAO Changlin, CHEN Feng, HE Wei, GUAN Yong,LYU Jiaju, LI Shanjun, DING Sentai. Application of CT three-dimensional reconstruction modified R.E.N.A.L. score in 50 cases of laparoscopic partial nephrectomy [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 52-57.
[3] SUN Zeyu, CHEN Ying, LIN Jiaxiang, LIU Juan, ZHAO Weiming. Influence of inositol polyphosphate-4-phosphatase type II on the proliferation and apoptosis of cervical cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 1-6.
[4] WANG Moulong, CHEN Yongkun, XING Deguang, QU Liangsuo, WANG Chengwei. A clinical analysis of transcranial Doppler in predicting delayed cerebral ischemia after ruptured aneurysm surgery [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 38-41.
[5] ZHANG Peipei, LIU Dequan, WANG Bei, HE Shuqian, LI Fei, DING Hongyu, SUN Hongjun. Sonographic findings and pathological features of non-mass pure ductal carcinoma in situ [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 54-58.
[6] DONG Wei, XING Naidong, LÜ Jiaju, LIU Shuai, SUN Liang, CAO Qingwei, DONG Yuhao, LIU Zhao, DING Sentai. The therapeutic efficacy of a potent KSP inhibitor S(MeO)TLC against docetaxel-resistant prostate cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 23-30.
[7] ZHAO Zuohui, LI Cuiling, WANG Daoguang, WANG Fengqin, QU Hongyi, DING Sentai, GONG Jing, LÜ Jiaju, YANG Jinghua. Effect of MnSOD acetylation on the proliferation and apoptosis of clear cell renal cell carcinoma cell line 786-O [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 31-35.
[8] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 130-132.
[9] MENG Fanchao, FENG Lu, SHAO Guangrui. FOXM1 regulates transcription of SYK in breast cancer cell line MCF-7 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 19-24.
[10] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 125-126.
[11] LIN Jiaxiang, GUO Zijia, SU Peng, WANG Xiao, GUO Yaxin, WU Xiaojuan, XIANG Lei, ZHOU Zhiqiang, WANG Yan, CUI Xiujie, PAN Aifeng, GUO Chenghao. The role of CIP2A in the transformation of breast ductal epithelium and prognosis of invasive breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 100-106.
[12] LU Heng, LIU Yanguo, LI Shuguang, CHEN Xiaokang, TIAN Qi, YI Cuihua, WANG Xiuwen. Regulation of epithelial ovarian carcinoma SKOV-3 cell migration by YKL-40 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 33-38.
[13] ZHAO Lu, JIAO Jun, ZHANG Teng, JIAO Xinlin, CUI Baoxia. Expression of LXRα in ovarian carcinoma and effects of T0901317 on SKOV3 cell line [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 49-53.
[14] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(12): 86-89.
[15] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(11): 95-96.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!